tiprankstipranks
Fuso Pharmaceutical Industries,Ltd. (JP:4538)
TSE/TYO:4538
Japanese Market

Fuso Pharmaceutical Industries,Ltd. (4538) Stock Price & Analysis

0 Followers

4538 Stock Chart & Stats

Day’s Range¥0 - ¥0
52-Week Range¥1,813.67 - ¥2,475.00
Previous Close¥2,375
Volume19.40K
Average Volume (3M)11.19K
Market Cap
¥20.83B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.9
Beta0.39
Aug 08, 2024
EPS EstimateN/A
Dividend Yield2.98%
Share Statistics
EPS (TTM)159.90
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume11,186
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Options Prices

Currently, No data available
---

Ownership Overview

0.00%2.74%1.09%96.17%
0.00%
Insiders
1.09% Other Institutional Investors
96.17% Public Companies and
Individual Investors

4538 FAQ

What was Fuso Pharmaceutical Industries,Ltd.’s price range in the past 12 months?
Fuso Pharmaceutical Industries,Ltd. lowest stock price was ¥1813.67 and its highest was ¥2475.00 in the past 12 months.
    What is Fuso Pharmaceutical Industries,Ltd.’s market cap?
    Currently, no data Available
    When is Fuso Pharmaceutical Industries,Ltd.’s upcoming earnings report date?
    Fuso Pharmaceutical Industries,Ltd.’s upcoming earnings report date is Aug 08, 2024 which is in 20 days.
      How were Fuso Pharmaceutical Industries,Ltd.’s earnings last quarter?
      Fuso Pharmaceutical Industries,Ltd. released its earnings results on May 10, 2024. The company reported ¥17.72 earnings per share for the quarter, beating the consensus estimate of N/A by ¥17.72.
        Is Fuso Pharmaceutical Industries,Ltd. overvalued?
        According to Wall Street analysts Fuso Pharmaceutical Industries,Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Fuso Pharmaceutical Industries,Ltd. pay dividends?
          Fuso Pharmaceutical Industries,Ltd. pays a Annually dividend of ¥40 which represents an annual dividend yield of 2.98%. See more information on Fuso Pharmaceutical Industries,Ltd. dividends here
            What is Fuso Pharmaceutical Industries,Ltd.’s EPS estimate?
            Fuso Pharmaceutical Industries,Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Fuso Pharmaceutical Industries,Ltd. have?
            Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding.
              What happened to Fuso Pharmaceutical Industries,Ltd.’s price movement after its last earnings report?
              Fuso Pharmaceutical Industries,Ltd. reported an EPS of ¥17.72 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.446%.
                Which hedge fund is a major shareholder of Fuso Pharmaceutical Industries,Ltd.?
                Currently, no hedge funds are holding shares in JP:4538
                ---

                Fuso Pharmaceutical Industries,Ltd. Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                Similar Stocks
                Company
                Price & Change
                Follow
                Oncolys BioPharma, Inc.
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis